We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Transcatheter Aortic Valve Replacement.
- Authors
Feldman, Arthur M.; DiSesa, Verdi J.
- Abstract
The authors comment on the approval by the U.S. Food and Drug Administration (FDA) of transcatheter aortic valve replacement (TAVR) for the treatment of patients considered inoperable and the expansion of the indication to include patients at high risk of surgical aortic valve replacement (SAVR). Topics covered include concerns on the numerator of the TAVR value equation, regional centers to ensure the quality of TAVR and control utilization, and long-term benefit of TAVR.
- Subjects
UNITED States. Food &; Drug Administration; AORTIC valve surgery; MEDICAL quality control; AORTIC valve diseases; AORTIC valve abnormalities
- Publication
JAMA: Journal of the American Medical Association, 2014, Vol 312, Issue 1, p25
- ISSN
0098-7484
- Publication type
Opinion
- DOI
10.1001/jama.2014.4606